Daniel L. Zabrowski
No más puestos en curso
Perfil
Daniel L.
Zabrowski founded M2SC Consulting LLC.
He is Executive Chairman for Nimble Therapeutics, Inc. He is also on the board of 8 other companies.
He previously occupied the position of Head-Roche Sequencing Solutions at Roche Holding AG President-Roche Sequencing Unit at Ventana Medical Systems, Inc. and Global Head-Drug Regulatory Affairs at Roche Pharma (Schweiz) AG (both are subsidiaries of Roche Holding AG), Associate Director at Fujisawa Healthcare, Inc., Executive Director-Drug Regulatory Affairs at Syntex (USA), Inc. and Research Investigator at G.D.
Searle LLC.
Daniel L.
Zabrowski received a doctorate from Indiana University and an undergraduate degree from St. Louis University.